Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
RMD Open|November 28, 2017
EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology reportMatteo Bottai, Anna Tjärnlund, Giola Santoni, et al.
Rheumatology International|October 22, 2022
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) surveyLeonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, et al.
Rheumatology (Oxford, England)|September 26, 2024
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD datasetMarco Fornaro, Vincenzo Venerito, Maria Rosa Pellico, et al.
The New England Journal of Medicine|March 30, 2026
A Phase 3 Trial of Brepocitinib in DermatomyositisRuth Ann Vleugels, Julie J Paik, Iazsmin Bauer Ventura, et al.
Plos One|June 27, 2019
Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencingJames S Floyd, Katarzyna M Bloch, Jennifer A Brody, et al.
The Lancet. Neurology|August 10, 2019
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trialMichael G Hanna, Umesh A Badrising, Olivier Benveniste, et al.
Neurology|February 18, 2021
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENTAnthony A Amato, Michael G Hanna, Pedro M Machado, et al.
Rheumatology (Oxford, England)|March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveysKshitij Jagtap, R Naveen, Jessica Day, et al.
Rheumatology (Oxford, England)|March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD studyLeonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.
Rheumatology (Oxford, England)|April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveysNaveen R, Parikshit Sen, Zoltán Griger, et al.
Pageof 18